Fresenius Medical Care AG (FMS)

NYQ – Real vaqt narxi. Valyuta: USD

23.73

-0.14 (-0.61%)

Bozor ochiq: Aug 12, 2026, 3:45 PM EDT

24.01

+0.14 (0.59%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

05.08.2026

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.

04.08.2026

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

04.08.2026

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care AG & Co. KGaA NYSE: FMS reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year outlook despite weaker U.S. treatment volumes and anticipated reimbursement-related headwinds in the second half.

04.08.2026

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Shares fell, wiping out most of their gains since the start of the year, after the German dialysis specialist reported another decline in U.S. treatment volumes in the second quarter.

04.08.2026

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

Fresenius Medical Care shares fell in early trade on Tuesday, as investors looked past a second-quarter profit beat to focus on a fresh disappointment in U.S. patient volumes ‌and the management's decision to merely confirm, not raise, the full-year guidance.

03.08.2026

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

Fresenius Medical Care on Monday reported second-quarter operating income well ahead of market expectations and reaffirmed its full-year outlook, ‌as its cost-cutting programme and favourable U.S. reimbursement rates offset a deepening decline in patient treatment volumes.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
FMS	BNP Paribas Exane	Underperform	undefined >> $20	July 28th 2026

Fresenius Medical Care AG (FMS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Fresenius Medical Care AG (FMS)

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

Videolar

No Data

Reytinglar oshishi / pasayishi

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

Videolar

No Data

Reytinglar oshishi / pasayishi

Search stocks

Fresenius Medical Care AG (FMS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Fresenius Medical Care AG (FMS)

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

Videolar

No Data

Reytinglar oshishi / pasayishi

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook

Videolar

No Data

Reytinglar oshishi / pasayishi